Pharmafile Logo

Meet OPEN Health and Pharmerit Experts at the World Orphan Drug Virtual USA Congress

August 24, 2020 |  

Join OPEN Health and Pharmerit – an OPEN Health Company at the World Orphan Drug Virtual Congress from August 24-27, 2020, as we present:

Advanced Therapies Commercial: Tuesday, August 25
Succeeding with Star Wars Medicine: Translating the Science and Value of Gene Therapy to Key Stakeholders

Gavin Jones, Director of Rare Disease, OPEN Health

PANEL: Wednesday, August 26
Bridging the Clinical Evidence Gap for Payers – Examining Recent Cases of Real-World Evidence for Reimbursement

Shelby Corman, Real-World Evidence and Data Analytics Lead, Pharmerit

Pink divider

OPEN Health is the only integrated agency that combines the depth of rare disease knowledge with the breath of discipline expertise across medical affairs, commercial, HEOR and market access.

OPEN Health’s Evidence and Access practice is a best in class global HEOR and market access consultancy that specialises in identifying client critical issues and building bespoke integrated solutions to support companies operating in rare disease and improve patient outcomes.

The Patient and Brand Communications practice at OPEN Health combines a deep focus in patient engagement (patient journey mapping and patient support programmes), PR (brand, disease awareness, corporate and internal communications) and advertising.

The Medical Communications practice provides expertise in Medical Affairs content and consultancy, publication planning and management, medical education, and internal training.

In addition to extensive rare disease experience we have delivered projects for over half the advanced therapies that have been launched in the United States and Europe.

Pink divider

Our executive team will be available to speak with you regarding how OPEN Health and Pharmerit can support you in the fight against rare diseases. Contact Gavin Jones today to set up a meeting.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

Digital Therapeutics Landscape in Europe

OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK

OPEN Health’s virtual reflections on the World Orphan Drug Congress US

Another congress attended in this virtual world with learnings gathered and connections made across the rare disease community. It was great to be joined by many colleagues from all our...

A day in the life of the Global Head of Publications

We asked Mina Patel to give us an insight into her role as Global Head of Publications at OPEN Health

Striving to become more patient-centric?

Explore more with OPEN Health

Meet OPEN Health and Pharmerit Experts at the World Orphan Drug Virtual USA Congress

Join OPEN Health and Pharmerit – an OPEN Health Company at the World Orphan Drug Virtual Congress from August 24-27, 2020, as we present:Advanced Therapies Commercial: Tuesday, August 25Succeeding with Star Wars...

OPEN Health at the World Orphan Drug Conference USA

Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !

OPEN Health Medical Communications is awarded Medical Affairs Agency of The Year at the Communiqué Awards 2020

We are delighted to announce that OPEN Health Medical Communications was named Medical Affairs Agency of the Year at the virtual 2020 Communiqué Awards ceremony on 02 July 2020.

Candice Subero to Lead Global Marketing for OPEN Health

OPEN Health is pleased to announce that Candice Subero has been named Global Marketing Lead, effective June 4, 2020. Candice will oversee strategic communications and marketing efforts across all OPEN...

The RARE Youth Revolution has begun

OPEN Health are proud to support RARE Revolution Magazine who have launched a dedicated RARE youth online platform powering up the voices of the youth rare disease community.